Study Title
 |
Principal
Investigator |
Disease
Category |
 |
|
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia
|
|
|
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
|
Laura Johnston
|
Myeloproliferative Disorders
Leukemia
Lymphoma
Graft vs Host Disease
Myelodysplastic Syndromes
Multiple Myeloma
|
|
|
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Phase II Intergroup Clinical Trial For Adolescents & Young Adults With Untreated ALL
|
Michaela Liedtke
|
Leukemia
|
|
|
Phase I/II of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients with Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
Daniel Aaron Pollyea
|
Leukemia
|
|
|
Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
|
Laura Johnston
|
Leukemia
|
|
|
An Open-Label, Dose Escalation, Phase 1 Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients with Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
|
Clare J. Twist M.D.
|
Leukemia, Lymphocytic, Acute
|
|
|
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
|
Laura Johnston
|
Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes
|
|
|
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
|
Peter L Greenberg
|
Leukemia
Bone Marrow Neoplasms
|
|
|
Study to Assess Compliance With Long-Term MercaptopurineTreatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
|
Jason Robert Gotlib
|
Myeloproliferative Disorders
Mastocytosis, Systemic
Leukemia, Mast-Cell
|
|
|
Phase II study of Atorvastatin safety and antitumor effects in non-Hodgkin's Lymphoma
|
Dean Felsher
|
Leukemia
Lymphoma, Non-Hodgkin
|
|
|
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
|
Bruno Carneiro de Medeiros
|
Leukemia, Myelocytic, Acute
|
|
|
Phase II Temozolomide in Acute Myeloid Leukemia Patient Age >= 60 Yrs & Poor Risk/Refractory Disease
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
|
Steven Edward Coutre
|
Leukemia, Lymphocytic, Acute
|
|
|
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL (STAR-1)
|
Steven Edward Coutre
|
Leukemia, Promyelocytic, Acute
|
|
|
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
|
Steven Edward Coutre
|
Leukemia, Hairy Cell
|
|
|
Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia, Myeloid
|
|
|
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
|
Steven Edward Coutre
|
Leukemia
Leukemia, Myeloid
Leukemia, Myelocytic, Acute
Lymphoma, T-Cell, Cutaneous
|
|
|
Dasatinib for CML or Philadelphia Chromosome Positive ALL previously on START protocols
|
Steven Edward Coutre
|
Leukemia, Myeloid, Chronic
|
|
|
Gemtuzumab and Combination Chemothearpy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
|
Steven Edward Coutre
|
Leukemia
|
|
|
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
|
Dr. Neyssa Marina
|
Leukemia
|
|
|
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
|
Steven Edward Coutre
|
Leukemia, Myeloid, Chronic
|
|
|
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
|
Steven Edward Coutre
|
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
|
|
|
Vorinostat and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
|
Bruno Carneiro de Medeiros
|
Leukemia
|
|
|
Phase I/II Combination 5-azacitidine and Gemtuzimab Ozogamycin for Relapsed AML
|
Bruno Carneiro de Medeiros
|
Leukemia, Myelocytic, Acute
|
|
|
Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma
|
Ranjana Hira Advani
|
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
Lymphoma, Small-Cell
|
|
|
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
|
Stanley L Schrier
|
Leukemia
Amyloidosis
|
|
|
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
|
Peter L Greenberg
|
Leukemia
Carcinomas (including Squamous Cell and Adenocarcinoma)
Myelodysplastic Syndromes
|
|
|
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
|
Gary V Dahl
|
Leukemia
Leukemia, Myeloid
|
|
Study Title
|
Principal
Investigator |
Disease
Category |
|
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic
Leukemia, B-Cell
|
|
Study of Intravenously Administered SNS-032 in Patients With Advanced B-Lymphoid Malignancies
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic, Chronic
Multiple Myeloma
|
|
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia
Mastocytosis, Systemic
Hypereosinophilic Syndrome
Mastocytosis
|
|
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
(Completed)
|
Steven Edward Coutre
|
Leukemia
Waldenstrom Macroglobulinemia
Lymphoma, Non-Hodgkin
Multiple Myeloma
|
|
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting)
|
Dr. Neyssa Marina
|
Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
|
|
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
(No longer recruiting)
|
Gary V Dahl
|
Leukemia
Lymphoma
Tumor Lysis Syndrome
Hyperuricemia
|
|
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
(No longer recruiting)
|
Dr. Neyssa Marina
|
Leukemia
Myelodysplastic Syndromes
|
|
Allogeneic Transplantation for Patients with Acute Leukemia or CML
(No longer recruiting)
|
Ginna Laport
|
Leukemia, Lymphocytic, Acute
|
|
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
(No longer recruiting)
|
Sally Arai
|
Leukemia
Multiple Myeloma
|
|
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
(No longer recruiting)
|
Robert S Negrin
|
Myeloproliferative Disorders
Acute Disease
Leukemia, Myeloid, Chronic
Myelodysplastic Syndromes
|
|
Transplantation for Patients with Chronic Lymphocytic Leukemia
(No longer recruiting)
|
Robert S Negrin
|
Leukemia, Lymphocytic, Chronic
|
|
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
(No longer recruiting)
|
Laura Johnston
|
Leukemia, Myelocytic, Acute
|
|
Monoclonal Antibody (mAb) 216 with Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia, Lymphocytic
|
|
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
(No longer recruiting)
|
Steven Edward Coutre
|
Leukemia
|
|
Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
(Completed)
|
Gary V Dahl
|
Leukemia, T-Cell
|
|
An Open-Label, Multicenter, Expanded Access Study of Oral AMN107 in Adult Patients With Imatinib (GlivecŪ/GleevecŪ) - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia, Myeloid, Chronic
|
|
Biomarker To Evaluate protein Profiles of neutropnic Fever/Infection with Acute or Chronic Leukemias
(No longer recruiting)
|
Jason Robert Gotlib
|
Leukemia, Myeloid
Leukemia, Lymphocytic
|
|
Trial Administration